Research & Development
12 July 2024 - Kolon TissueGene, Inc., an advanced cell therapies company, announced on Thursday that it has completed its US phase three clinical trials for Knee Osteoarthritis.The company has comple...
12 July 2024 - Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specialising in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and pa...
11 July 2024 - Clinical-stage biotechnology company Biophytis SA (Euronext Growth Paris:ALBPS) (OTC:BPTSY) announced on Thursday that it has received Investigational New Drug (IND) approval from the U...
11 July 2024 - Danish pharmaceutical company Novo Nordisk A/S (CPH:NOVO-B) (NYSE:NVO) revealed on Wednesday that the US Food and Drug Administration (FDA) has issued a Complete Response Letter relatin...
11 July 2024 - Rgenta Therapeutics, a US-based biotechnology company involved in the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological d...
10 July 2024 - Biopharmaceutical company Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) on Wednesday announced the acquisition of avexitide, a novel GLP-1 receptor antagonist, from Eiger BioPharmaceuticals...